2 completed, 1 active not recruiting, 1 recruiting, 1 terminated. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 2, Active not recruiting 1, Recruiting 1, Terminated 1 |
Follow Follicular Thyroid Cancer: new trials by email Literature Review of Follicular Thyroid Cancer trials Research Report on Follicular Thyroid Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC Selpercatinib, Sodium Iodine I-131, rhTSH - Thyroid Cancer, Thyroid Carcinoma | Phase 2 | Recruiting | Massachusetts General Hospital | 30 | 2023-03-01 | 2024-12-12 |
| PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer Trametinib, Dabrafenib, PDR001 - Thyroid Cancer, Thyroid Cancer, Follicular | Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 19 | 2020-09-02 | 2026-09-17 |
| Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer Lenvatinib, Sorafenib, Cabozantinib - Thyroid Cancer, Thyroid Cancer, Medullary | Phase 2 | Terminated | H. Lee Moffitt Cancer Center and Research Institute | 6 | 2018-08-06 | 2021-07-14 |
| Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer dabrafenib, trametinib - Follicular Thyroid Cancer, Insular Thyroid Cancer | Phase 2 | Completed | Bhavana Konda | 53 | 2012-11-07 | 2025-08-24 |
| Sutent Adjunctive Treatment of Differentiated Thyroid Cancer SU011248, Sutent - Papillary Thyroid Cancer, Follicular Thyroid Cancer | Phase 2 | Completed | Medstar Health Research Institute | 23 | 2008-04-01 | 2020-08-05 |
Adenocarcinoma, Follicular (5) · Thyroid Cancer, Papillary (5) · Thyroid Neoplasms (5) · Adenoma, Oxyphilic (1) · Carcinoma, Medullary (1) · Thyroid Diseases (1) · Thyroid cancer, Hurthle cell (1) · Thyroid cancer, follicular (1) · Thyroid cancer, medullary (1)
Adenocarcinoma (5) · Adenocarcinoma, Papillary (5) · Carcinoma (5) · Endocrine Gland Neoplasms (5) · Endocrine System Diseases (5) · Head and Neck Neoplasms (5) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms by Site (5) · Neoplasms, Glandular and Epithelial (5) · Thyroid Diseases (4) · Adenoma (1) · Carcinoma, Neuroendocrine (1) · Neoplasms, Ductal, Lobular, and Medullary (1) · Neoplasms, Germ Cell and Embryonal (1)
dabrafenib (2) · trametinib (2) · Iodine-131 (1) · Sorafenib (1) · Sunitinib (1) · Thyrotropin Alfa (1) · cabozantinib (1) · lenvatinib (1) · selpercatinib (1) · spartalizumab (1) · vandetanib (1)
Bhavana Konda (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Massachusetts General Hospital (1) · Medstar Health Research Institute (1) · Memorial Sloan Kettering Cancer Center (1)
United States (5)
Alan L Ho, MD, PhD (1) · Bhavana Konda, MD (1) · Christine H. Chung, M.D. (1) · Kenneth D Burman, MD (1) · Lori J. Wirth, MD (1)